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Objective: One of the most common forms of urinary dysfunction is related to the development of over-
active bladder (OAB) dysfunction. Solifenacin is a relatively new selective antimuscarinic agent that has
been shown to be particularly useful in treating OAB dysfunction in both men andwomen. Experimentally,
we have previously demonstrated that OAB is associated with the generation of free radicals and oxidative
damage to the bladder. We tested the hypothesis that the combination of solifenacin þ coenzyme Q10
(CoQ10) þ a-lipoic acid (a-LA) is more effective in treating OAB than the individual compounds.
Materials and Methods: In total, 48 male New Zealand White rabbits were separated into 8 groups of 6
rabbits each. The following oral treatments were given to each group: groups 1 and 5 received vehicle
(saline); groups 2 and 6 received solifenacin; groups 3 and 7 received CoQ10 þ a-LA; and groups 4 and 8
received solifenacin þ CoQ10 þ a-LA. After 3 weeks of treatment (by oral gavage), rabbits in groups 1 to 4
received partial outlet obstruction. The rabbits continued their treatments for 4 weeks following surgery.
At the end of this 4-week period, each rabbit received cystometry and then underwent an in situ study
for OAB.
Results: The results clearly demonstrated that obstructive bladder dysfunction and the level of OAB were
reduced in all three treatment groups, but the combination of solifenacin þ antioxidants was signiﬁ-
cantly more effective than either solifenacin or antioxidants alone.
Conclusion: The addition of the antioxidants CoQ10 þ a-LA worked synergistically with solifenacin in the
treatment of obstructive bladder dysfunction and OAB.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
The urinary bladder is a smooth-muscle organ, which functions
to collect and store urine at low intravesical pressures, and then to
periodically expel the urine via highly coordinated sustained con-
tractions.1e3 One of the most common forms of dysfunction is
related to the development of an overactive bladder (OAB).4,5 In
males, this condition is often accompanied by benign prostatic
hyperplasia (BPH) and results in the symptoms of urgency and
frequency. In females, OAB can result in urgency and frequency, andcy and Health Sciences, 106
n).
ciation. Published by Elsevier Taiwcan also induce urge incontinence. The incidence of incontinence
signiﬁcantly increases with age and is especially prevalent after
menopause.5,6
Most forms of OAB are mediated through parasympathetic
nerves, and therefore involve the release of acetylcholine (Ach) and
stimulation of muscarinic receptors localized on detrusor smooth-
muscle membranes. Traditionally, treatment for OAB has been the
use of antimuscarinic agents.
Solifenacin is a relatively new selective antimuscarinic agent
(M-3) that has been shown to be particularly useful in treating OAB
dysfunction in both men and women.7e11 However, it is not clear
whether there is a selectivity for the muscarinic mechanisms
involved in OAB activity compared with muscarinic stimulation of
bladder contractions duringmicturition. Additionally, BPH-induced
bladder hypertrophy can alter the muscarinic receptor subtypean LLC. Open access under CC BY-NC-ND license.
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activity.1214 The etiology of bladder dysfunction secondary to BPH
(OAB and poor bladder contraction) is in part due to the generation
of free radicals and oxidative damage to the bladder’s smooth
muscles and nerves.15,16
Coenzyme Q10 (CoQ10) is a lipid-soluble cofactor found natu-
rally in mitochondria and carries out important biochemical func-
tions in mitochondrial inner membranes. CoQ10 serves as an
electron and proton carrier for energy coupling and helps maintain
an electrical gradient across cell membranes for ATP produc-
tion.17,18 CoQ10 also serves as a primary scavenger for free radicals
and an indirect stabilizer of calcium channels to decrease calcium
overload.
a-Lipoic acid (a-LA) is also naturally found in mitochondria, and
acts as a critical coenzyme for mitochondrial enzymes, pyruvate
dehydrogenase, and a-ketoglutarate dehydrogenase.19 Its reduced
form, dihydrolipoic acid, and other metabolites have strong anti-
oxidant effects as reactive oxygen species scavengers, and act as
chelators of such transition metals as magnesium (Mnþ), zinc
(Znþ) and copper (Cu).20,21 Supplementation with a-LA has also
been shown to be an effective glutathione (GSH) substitute and to
increase cellular GSH levels.22 The primary biological function of
GSH is to act as a nonenzymatic reducing agent, preventing
oxidative stress in most cells and helping to trap free radicals that
can damage DNA and RNA.
The combination of CoQ10 and a-LA has proven to be very potent
at preventing oxidative damage to the bladder caused by both direct
ischemia/reperfusion and partial outlet obstruction.23e25 This
combination of supplements signiﬁcantly protects against the
contractile, biochemical, and structural dysfunctions associated
with increased free radical production.
The current study was designed to evaluate the hypothesis that
solifenacinworks in synergy with CoQ10 and a-LA in the treatment
of obstructive bladder dysfunction and OAB dysfunction.
2. Materials and methods
All animal studies were approved by the Institutional Animal
Care and Use Committee (IACUC) of Stratton VA Medical Center,
Albany, NY. Our current study used both an in vivo and a novel in
situ model to study the effects of solifenacin with or without
antioxidants on the direct response of the bladder to intra-arterial
Ach, obstructive bladder dysfunction, and OAB dysfunction. These
experiments were based upon published techniques.10e14
2.1. Cystometry
Each rabbit was anesthetized with 1e3% isoﬂurane by inhala-
tion. The bladder was catheterized through the urethrawith an 8-Fr
Foley catheter and ﬁlled at 1 mL/minute warmed saline, while the
intravesical bladder pressure was continually monitored (by cyst-
ometry). If OAB was present, cystometry was stopped, and the
frequency and amplitude of the OAB were recorded, and then
cystometry was completed.
2.2. Partial outlet obstruction
Each rabbit was anesthetized with isoﬂurane, and the bladder
was catheterized with an 8-Fr Foley catheter via the urethra, and
then exposed through a midline incision. A 00 silk ligature was
snugly tied around the catheterized proximal urethra, and the
catheter was removed.26e28 This method has been shown to be an
excellent model of BPH-induced obstructive bladder dysfunction
in men.29,30 Approximately 50% of these rabbits developed OAB
as observed during cystometry. Those rabbits that showed OABprogressed to severe bladder dysfunction at a signiﬁcantly faster
rate than rabbits that did not show OAB. This result is similar to
what occurs in human males with BPH and OAB. The etiology of
obstructive bladder dysfunction is via ischemia/reperfusion and
free radical generation and damage.
2.3. In situ OAB31e33
After 4 weeks of obstruction, each rabbit was anesthetized as
described previously, and the right external carotid artery was
cannulated for blood pressure monitoring. A polyethylene catheter
was inserted through the rabbit’s right femoral artery until it
reached the lower abdominal aorta. A heparinized saline-ﬁlled
polyethylene catheter was used for intra-arterial administration
of Ach. The bladder was exposed through a midline incision of the
abdominal wall and it was catheterized through the bladder dome
with an 8-Fr Foley catheter for both monitoring of the bladder
pressure and infusion of saline. At this point, a ligature was placed
around the external proximal penis, the bladder was ﬁlled with
30mLwarmed saline, and the bladder pressurewasmonitored. Ach
was given intra-arterially, and the maximal pressure generated was
recorded. Within 30minutes, the majority of rabbits had developed
OAB, and the amplitude and frequency of contractile activity were
recorded.
Therefore, these models provided quantitative data on: (1) the
micturition pressure; (2) the volume that initiated micturition; (3)
compliance (taken from the cystometric curve); (4) the response to
intra-arterial Ach; (5) the number of animals that developed
overactivity; and (6) the amplitude and frequency of bladder
overactivity.
2.4. Experimental design
Forty-eight male New Zealand White rabbits were separated
into eight groups of six rabbits each. The following oral treatments
were given: groups 1 and 5 received the vehicle (saline); groups 2
and 6 received solifenacin (0.3 mg/kg/day); groups 3 and 7 received
100 mM/kg/day a-LA þ 5 mg/kg/day CoQ10; and groups 4 and 8
received 0.3 mg/kg/day solifenacin þ 100 mM/kg/day a-LA þ 5 mg/
kg/day CoQ10.
After 3 weeks of treatment (by oral gavage), rabbits in groups 1
to 4 were anesthetized with 1e3% isoﬂurane and received partial
outlet obstruction as detailed above. The rabbits continued their
treatments for 4 weeks following surgery.
Immediately following the in situ experiment, the bladder was
excised and weighed, and three full-thickness bladder strips were
taken for in vitro contractile studies. The remainder of the bladder
was separated by blunt dissection into muscle and mucosal
compartments, frozen under liquid nitrogen, and stored at e80C
for biochemical experiments.
2.5. In vitro contractile studies
Each isolated strip was suspended between platinum electrodes
in an individual 15-mL bath containing Tyrode’s solution with
1 mg/mL glucose and equilibrated with 95% oxygen and 5% carbon
dioxide at 37C. After 30 minutes of equilibration, 2 g of tension
were placed on each strip. This is the tension required to obtain
maximal contractile responses to ﬁeld stimulation (FS). After 15
minutes of equilibration at 2 g of tension, each strip was subjected
to FS at 2 Hz, 8 Hz, and 32 Hz with 80 V and a 1-millisecond
duration; the maximal response was recorded on a model D
Grass polygraph; and the analog signal was digitized using the
Polyview system. At 10 minutes after FS, each strip was stimulated
by the addition of 10 mM carbachol, and the maximal contractile
Table 1
Data from the overactive bladder (OAB) model are presented as the percentage of animals showing OAB, and the frequency and amplitude of OAB for each group
Solifenacin CoQ þ aLA Solifenacin þ CoQ þ aLA
Measurement Control Obstructed Control Obstructed Control Obstructed Control Obstructed
Bladder weight (g) 2.2  0.23 9.8  1.4a 2.6  0.25 9.18  0.6a 2.4  0.4 7.7  1.5a 2.2  0.21 5.8  1.0a,b
Compliance (cmH2O/20% capacity) 5.7  0.46 14  0.25a 5.77  0.46 5.9  1.0b 5.8  0.5 5.2  0.8b 5.8  0.4 6.9  0.6b
Micturition pressure (cmH2O) 21 þ 1.3 40  6.0a 19.3  1.3 31.6  6.0a 24.8  1.3 35.0  4.0a 20.1  2.0 38.5  6.0a
Volume at micturition (mL) 20  7 30  12 30  10 30  8 22  10 20  10 18  3 18  3
Percentage of rabbits showing OAB 50 66 16 66 16 33 16 33
Amplitude of OAB (cmH2O) 3.1  1.1 8.2  1.5a 0.35  0.1b 3.6  0.8a,b 1.3  0.2a 4.4  0.5a,b 1.0  0.2a 2.1  0.4a
Frequency of OAB (no. of contractions/10 min) 1.3  0.3 5.5  0.9a 0.1  0.1a 3.0  0.2a,b 0.4  0.1a 1.8  0.5a,b 1.8  0.5 2.5  1.0a,b
Response to intra-arterial acetylcholine cmH2O/g 3.9  0.07 1.5  0.22a 3.77  0.2 1.4  0.15a 3.6  0.5 2.1  0.1a 4.0  0.4 3.1  0.1a
Each value is the mean  SEM of six individual rabbits per group, except for the percentage of animals showing OAB values.
a p < 0.05 compared to the control group for each treatment.
b p < 0.05 compared to the obstructed group without group (vehicle).
CoQ ¼ coenzyme Q10; aLA ¼ a-lipoic acid; Ach ¼ acetylcholine; OAB ¼ overactive bladder.
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minute intervals with fresh, warmed, oxygenated Tyrode’s solu-
tion and then stimulated by the addition of 1 mM of ATP. After
another series of washes, the strips were stimulated with 120 mM
of potassium chloride (KCl), and the maximal response was recor-
ded. We found that producing doseeresponse curves with these
agents produced signiﬁcant fatigue, which then made the data
unreliable. Giving a single maximal dose did not cause fatigue.
Part 1 reports on the urodynamic and physiological results of
this study and part 2 reports on the biochemical aspects of this
study.Figure 1. Cystometric curves for all groups. Each line is the mean  standard error of
mean of six individual rabbits.3. Results
Partial outlet obstruction caused a signiﬁcant increase in
bladder weight (p < 0.05) in all groups (Table 1). However, bladder
weight in the obstructed antioxidant group and the obstructed
solifenacin þ antioxidant groups was signiﬁcantly lower than that
of the obstructed group with vehicle. Additionally, the bladder
weight in the obstructed solifenacin þ antioxidant group was
signiﬁcantly lower than that of the obstructed antioxidant group. In
general, the lower the obstructed bladder weight, the greater the
contractile and metabolic function.
Figure 1 displays the cystometric curves for the various groups.
The obstructed group with vehicle had a steeper curve than any of
the other groups, showing that the compliance of this group was
low (poor) compared with the compliance of the treatment groups.
Quantitative values for compliance are presented in Table 1. None of
the treatments had any effect on the compliance of the control
groups. The obstructed group with vehicle had a signiﬁcantly lower
(poorer) compliance than any of the other obstructed groups. All
treatments resulted in the compliance returning to control values.
Obstruction resulted in signiﬁcant and similar increases in all
micturition pressures (Table 1). There were no signiﬁcant differ-
ences among the groups in the volume at micturition primarily
because of the large standard errors. The combination of
solifenacin þ antioxidants had the most consistent volume at
micturition. The percentage of rabbits showing OAB dysfunction,
and the amplitude and frequency of OAB are presented in Table 1.
Since therewere only six rabbits per group, no standard error of the
mean could be calculated; however, it appeared that all treatments
reduced the percentage of rabbits showing OAB in the control
groups. Obstruction increased the percentage of rabbits showing
OAB in all groups; however, this increased percentage in the anti-
oxidant and solifenacin þ antioxidants groups was lower than that
compared with the other two groups. This ﬁnding was unexpected
and may have important clinical implications.There appeared to be a decrease in the amplitude of OAB in both
control and obstructed rabbits associated with all treatments,
especially in the solifenacinþ antioxidants obstructed group. There
also appeared to be a decrease in the frequency of OAB in the
obstructed bladders of all treatment groups and in the control
bladders of the solifenacin þ antioxidant groups.
Figure 2 displays the in situ response to intra-arterial Ach.
Obstruction caused signiﬁcant decreases in the response to Ach in
all groups. However, the Ach response of the obstructed group
treated with the combination of solifenacin þ antioxidants was
signiﬁcantly greater than that of the obstructed group with vehicle.
Figure 3 shows the contractile response to FS, carbachol, and KCl
by control bladders. There were no effects of any of the treatments
on the control responses (data not shown). Figure 4 shows the
effect of partial outlet obstruction on the contractile responses to all
forms of stimulation as a percentage of the control response.
Contractile responses of the combined solifenacin þ antioxidant
obstructed group to all forms of stimulation were signiﬁcantly
increased compared with those in the obstructed group with
vehicle. Contractile responses of the antioxidant obstructed group
to all forms of stimulation, except for 2 Hz FS, were signiﬁcantly
increased compared with those in the obstructed group with
vehicle. Contractile responses of the solifenacin obstructed group to
Figure 2. In situ response of the rabbit bladder to intra-arterial acetylcholine. Each bar
is the mean  standard error of mean of six individual rabbits (p < 0.05). aSigniﬁcantly
different from the control; bsigniﬁcantly different from no-treatment group.
Figure 4. Effect of treatment on the contractile responses to ﬁeld stimulation, carba-
chol, and potassium chloride. Data for the obstructed groups are presented as a percent
of the control. Each bar is the mean  standard error of mean of six individual rabbits
(p < 0.05). aSigniﬁcantly different from the control; bsigniﬁcantly different from the
no-treatment group.
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those in the obstructed group with vehicle.4. Discussion
Antimuscarinic agents have proven to be clinically effective in
treating OABs in both men and women.34e36 These drugs relax the
bladder by muscarinic cholinergic inhibition, which makes them
useful drugs for treating an unstable bladder. Since both bladder
overactivity and micturition are based on neuronal release of Ach
and muscarinic receptor stimulation, it is important to directly
compare the effect of antimuscarinic agents on these two cholin-
ergic systems in a controlled, quantitative manner, in which the
true sensitivity can be determined for each system. Moreover, it
would be beneﬁcial to discover treatment modalities that address
overactivity without affecting the bladder contractile force. This
beneﬁt might be accomplished through the use of antioxidants as
mentioned in the Introduction section. For the current studies, we
chose to use a combination of CoQ10 and a-LA because, as
mentioned earlier, this combination of antioxidants has been
shown to bemost effective in treating partial outlet obstruction and
in vivo ischemia/reperfusion.23,24,37
CoQ10 is a lipid-soluble cofactor found naturally in mitochon-
dria that carries out important biochemical functions inFigure 3. Contractile responses to ﬁeld stimulation, carbachol, and potassium chloride.
Each bar is the mean  standard error of mean of six individual rabbits.mitochondrial inner membranes. CoQ10 serves as an electron and
proton carrier for energy coupling, and helps maintain an electrical
gradient across cell membranes for ATP production.17,18 CoQ10 also
serves as a primary scavenger of free radicals and an indirect
stabilizer of calcium channels to decrease calcium overload. Similar
to its effects in the bladder, preoperative oral CoQ10 therapy in
patients undergoing cardiac surgery increases myocardial and
cardiac mitochondrial CoQ10 levels, improves mitochondrial efﬁ-
ciency, and increases myocardial tolerance to in vitro hypoxia-
reoxygenation stress.38
In addition to its effects on the urinary bladder, a-LA protects
against hepatic ischemia/reperfusion injury and other forms of
oxidative stress in rats.39,40
These studies used two models of bladder overactivity. The ﬁrst
is an in situ method that creates OAB in normal rabbits and was
effectively used in studies on the effects of intravesical and intra-
vaginal treatments of bladder overactivity.31,32,41,42 The second is
a model of chronic partial bladder outlet obstruction. Approxi-
mately 50% of obstructed rabbits developed signiﬁcant OAB. In both
models, bladder damage was mediated in part by the generation of
free radicals and oxidative damage to nerves, mitochondria, and the
sarcoplasmic reticulum.15,16,4345 Partial outlet obstruction results
in signiﬁcant changes in the bladder structure, including detrusor
hypertrophy, mucosal hyperplasia, mucosal and detrusor angio-
genesis, and signiﬁcant collagen synthesis and deposition.29,4651
These structural changes include signiﬁcant damage to nerves,
synapses, mitochondria, and the sarcoplasmic reticulum.29,46,48
This structural damage plays a role in the dysfunction observed
in this model.
The following is a summary of our ﬁndings. The following
parameters of bladder function improved after pretreatment with
solifenacin alone: compliance; the number of control and
obstructed rabbits showing OAB; the amplitude and frequency of
OAB in control and obstructed rabbits; and contractile responses to
32 Hz FS, carbachol, and KCl. The following parameters of bladder
function improved after pretreatment with CoQ10 plus a-LA:
compliance; the number of obstructed rabbits showing OAB; the
amplitude and frequency of OAB of control and obstructed rabbits;
and contractile responses to 8 Hz FS and 32 Hz FS, carbachol, and
KCl. The following parameters of bladder function improved after
pretreatment with a combination of solifenacin, CoQ10, and a-LA:
compliance; the contractile response to in situ Ach; the number of
obstructed rabbits showing OAB; the amplitude of OAB of control
T. Topol et al. / Urological Science 22 (2011) 110e115114and obstructed rabbits; the frequency of OAB in obstructed rabbits
only; and contractile responses to 2 Hz FS, 8 Hz FS, and 32 Hz FS;
carbachol; and KCl.
5. Conclusion
Our ﬁndings indicated that all three forms of treatment were
effective in improving obstructed bladder function and reducing
the level of OAB in both control and obstructed rabbits. The
solifenacin-only and antioxidant-only groups were similar in their
effectiveness, but the combination of solifenacin and antioxidants
was more effective in improving more parameters than either of
the 2 therapies alone, thus supporting our original hypothesis.
Although our studies used an outlet obstruction model of OAB, we
believe that the combination of solifenacin and antioxidants would
be effective against nonobstructive OAB. This idea is supported by
studies that have shown that nonobstructive OAB can be treated by
antimuscarinic agents and antioxidants.52e54
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